Dr. Mark J. Tullman, MD

Dr. Tullman practices at Mercy Hospital St. Louis in Saint Louis, Missouri, part of Mercy.

Dr. Tullman's NPI, 1629082375, was assigned on July 28, 2006. Dr. Tullman graduated from University of Missouri, Columbia School of Medicine in 1997. Dr. Tullman holds Missouri license 2011013368.

Dr. Tullman's primary practice is Mercy Hospital St. Louis, at 615 New Ballas Road, Saint Louis, MO 63141 in St. Louis County. The practice phone is (314) 251-6000.

Dr. Tullman's primary practice is Mercy Hospital St. Louis in Saint Louis, Missouri, part of Mercy. Dr. Tullman is also affiliated with White Plains Hospital. The medical group on file is Mercy Neurology - Medical Tower B Suite 5003-B. Dmand AI also links Dr. Tullman to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tullman practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tullman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Tullman's licenses on file in 2 states: Missouri and New York.

CMS data shows 237 Medicare services from Dr. Tullman across 4 procedure codes in 2024, for 79 Medicare patients. Medicare paid $14,778 for them. Every service was in an office.

CMS counts 79 Medicare patients who saw Dr. Tullman in 2024. The largest group is under 65, with 40 patients. 68% of them have high cholesterol, and 63% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tullman's median patient age at 57, with 78% women.

In 2024, Dr. Tullman wrote 931 Medicare Part D claims for 147 patients. 89% of them were for generic drugs. CMS names the drug for 789 of them, across 20 drugs with 11 or more claims each, at $946,140 in total drug cost. In 2023, CMS named 489 claims across 16 drugs.

Dr. Tullman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Tullman, published from 2014 to 2023. The most frequent topics are Multiple Sclerosis. Dr. Tullman's most frequent co-authors are Rany A. Aburashed, DO, Benjamin M. Brucker, MD and Anne H. Cross, MD.

CMS Open Payments shows 2,924 general payments to Dr. Tullman from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Biogen, Inc. paid the most, $815,661. It also lists 7 research payments totaling $6,905 from 2021 to 2022.

Dr. Tullman graduated from University of Missouri, Columbia School of Medicine in 1997.